JMS Co

JMS Co EBIT per Share

The EBIT per Share of JMS Co (7702.T) as of Nov 2, 2026 is 15.61 JPY. In the previous year, EBIT per Share was 35.63 JPY — a change of -56.18% (lower).

EBIT per Share

15.61JPY

YoY

-56.18%

Last updated:

EBIT per Share of JMS Co is 2026 15.61 JPY. EBIT per Share of JMS Co was 2025 35.63 JPY. It decreases by -56.18% lower compared to the previous year.

The JMS Co EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2019
60.04 JPY
Jan 1, 2020
102.05 JPY
Jan 1, 2021
93.90 JPY
Jan 1, 2022
40.08 JPY
Jan 1, 2023
29.57 JPY
Jan 1, 2024
14.94 JPY
Jan 1, 2025
35.63 JPY
Jan 1, 2026
15.61 JPY
The JMS Co EBIT per Share history
YEAREBIT per ShareYoY
15.61JPY-56.18%
35.63JPY+138.54%
14.94JPY-49.49%
29.57JPY-26.22%
40.08JPY-57.31%
93.90JPY-7.99%
102.05JPY+69.97%
60.04JPY+54.54%
38.85JPY-14.41%
45.39JPY-22.21%
58.35JPY+276.27%
15.51JPY-57.99%
36.91JPY-43.53%
65.37JPY+51.52%
43.14JPY-45.46%
79.10JPY-28.22%
110.19JPY+25.75%
87.63JPY+86.71%
46.93JPY-18.23%
57.40JPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

JMS Co Stock analysis

What does JMS Co do? JMS Co., Ltd. generates revenue through the manufacture, sale, export, and import of medical devices and pharmaceuticals across its five geographical segments: Japan, Singapore, China, Philippines, and Germany. The company offers a range of products including infusion and nutrition products, dialysis products, surgery products, blood and cell products, and other related items. Key products such as infusion & transfusion sets, syringe pumps, surgical gowns, dialysis kits, peritoneal dialysate, microcatheters, and blood bags are sold to healthcare providers and institutions within these regions. The firm also provides maintenance services and other related services as part of its product portfolio. The company's primary customers are healthcare providers and institutions in Japan, Singapore, China, Philippines, and Germany, where it operates through its five geographical segments. These customers purchase medical equipment and drugs, including specific items like infusion & transfusion sets, dialysis kits, and surgical gowns. The firm's product lines are tailored to meet the needs of hospitals, clinics, and other medical facilities across its operational regions. JMS Co., Ltd. focuses on manufacturing and selling medical equipment and drugs, with a strong emphasis on products such as infusion & transfusion sets, syringe pumps, surgical gowns, and dialysis kits. The company's revenue streams are driven by the sale of these products and the provision of maintenance services. Its geographical segments ensure a diversified market presence, allowing it to serve various healthcare sectors in different countries. JMS Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about JMS Co stock

EBIT per Share of JMS Co is 15.61 JPY in 2026.

EBIT per Share of JMS Co changed from 35.63 JPY to 15.61 JPY, representing a -56.18% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share JMS Co since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — JMS Co

All Key Metrics — JMS Co